Showing results (2031-2040 of 2,127) with videos related to
Sort By:
Pageof 213
Pharmacopsychiatry|October 8, 2010
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trialsR Schennach-Wolff, H-J Möller, M Jäger, et al.Journal of Psychiatric Research|June 10, 2009
Attitude towards adherence in patients with schizophrenia at dischargeRebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 13, 2010
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?Rebecca Schennach-Wolff, Markus Jäger, Michael Obermeier, et al.Journal of Psychiatric Research|August 25, 2011
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorderRebecca Schennach-Wolff, Sebastian Meyer, Florian Seemüller, et al.Psychiatric Services (Washington, D.C.)|January 10, 2012
Predictors of relapse in the year after hospital discharge among patients with schizophreniaRebecca Schennach, Michael Obermeier, Sebastian Meyer, et al.European Archives of Psychiatry and Clinical Neuroscience|September 28, 2014
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.ACS Central Science|August 3, 2021
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2Razie Amraei, Wenqing Yin, Marc A Napoleon, et al.Pharmacopsychiatry|May 16, 2017
Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?Rebecca Schennach, Michael Obermeier, Florian Seemüller, et al.Schizophrenia Research|February 26, 2010
Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patientsM Jäger, M Riedel, M Obermeier, et al.Journal of Clinical Psychopharmacology|November 25, 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic studyRebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, et al.Pageof 213